Analysis Natrium Iodide Symporter Expression in Breast Cancer Subtypes for Radioiodine Therapy Response

Author:

Elliyanti AisyahORCID,Rusnita Dewi,Afriani Nita,Susanto Yayi Dwina Billianti,Susilo Veronica Y.,Setiyowati Sri,Harahap Wirsma Arif

Funder

Faculty of Medicine, Universitas Andalas.Indonesia

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging

Reference41 articles.

1. Ng CH, Bhoo Pathy N, Taib NA, et al. Comparison of breast cancer in Indonesia and Malaysia - a clinico-pathological study between Dharmais Cancer Centre Jakarta and University Malaya Medical Centre, Kuala Lumpur. Asian Pac J Cancer Prev. 2011;12:2943–6.

2. Leong SP, Shen Z, Liu T, Agarwal G, Tajima T, Paik N, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34:3208–24.

3. Perry CS, Otero JC, Palmer JL, Gross AS. Risk factors for breast cancer in east Asian women relative to women in the west. Asia Pac J Clin Oncol. 2009;5:219–31.

4. Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J, et al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res. 2015;5:2929–43.

5. Micali S, Bulotta S, Puppin C, Territo A, Navarra M, et al. Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer. BMC Cancer. 2014;14:303.

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Aspects Considered in Differentiated Thyroid Cancer for Radioiodine Therapy;Thyroid Cancer - The Road From Genes to Successful Treatment [Working Title];2022-11-07

2. Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges;Molecules;2022-08-16

3. Radioiodine for Graves’ Disease Therapy;Graves' Disease;2021-12-01

4. Glucose Transporters as a Target for Anticancer Therapy;Cancers;2021-08-20

5. Radiopharmaceuticals in Modern Cancer Therapy;Radiopharmaceuticals [Working Title];2021-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3